S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Sell every Stock except ONE (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
This Tech Stock Could be the Next Amazon (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
This Tech Stock Could be the Next Amazon (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Sell every Stock except ONE (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
This Tech Stock Could be the Next Amazon (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
This Tech Stock Could be the Next Amazon (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Sell every Stock except ONE (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
This Tech Stock Could be the Next Amazon (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
This Tech Stock Could be the Next Amazon (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Sell every Stock except ONE (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
This Tech Stock Could be the Next Amazon (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
This Tech Stock Could be the Next Amazon (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
NASDAQ:MDXH

MDxHealth - MDXH Stock Forecast, Price & News

$3.24
+0.09 (+2.86%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.13
▼
$3.37
50-Day Range
$2.61
▼
$7.15
52-Week Range
$2.47
▼
$10.95
Volume
126,021 shs
Average Volume
220,733 shs
Market Capitalization
$52.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

MDxHealth MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
270.4% Upside
$12.00 Price Target
Short Interest
Healthy
0.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of MDxHealth in the last 14 days
Based on 10 Articles This Week
Insider Trading
Acquiring Shares
$4 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.22) to ($1.02) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

323rd out of 996 stocks

Medical Laboratories Industry

9th out of 25 stocks

See Top Rated MarketRank™ Stocks Here

MDXH stock logo

About MDxHealth (NASDAQ:MDXH) Stock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Stock News Headlines

April 2, 2023 | americanbankingnews.com
MDxHealth (MDXH) vs. Its Rivals Head to Head Survey
April 2, 2023 | americanbankingnews.com
Contrasting MDxHealth (MDXH) and Its Competitors
April 2, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
April 2, 2023 | americanbankingnews.com
MDxHealth (MDXH) and Its Peers Critical Contrast
March 31, 2023 | americanbankingnews.com
Head-To-Head Survey: MDxHealth (MDXH) & Its Competitors
March 31, 2023 | americanbankingnews.com
MDxHealth (MDXH) versus Its Rivals Financial Analysis
March 30, 2023 | americanbankingnews.com
MDxHealth (MDXH) and Its Rivals Head to Head Review
March 30, 2023 | americanbankingnews.com
MDxHealth (MDXH) & Its Peers Critical Contrast
April 2, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
March 30, 2023 | americanbankingnews.com
Reviewing MDxHealth (MDXH) and Its Peers
March 28, 2023 | americanbankingnews.com
Reviewing MDxHealth (MDXH) and The Competition
March 27, 2023 | americanbankingnews.com
MDxHealth (MDXH) & Its Competitors Head-To-Head Review
March 26, 2023 | americanbankingnews.com
MDxHealth (MDXH) and Its Competitors Financial Analysis
March 24, 2023 | americanbankingnews.com
MDxHealth (NASDAQ:MDXH) Coverage Initiated by Analysts at William Blair
March 15, 2023 | marketwatch.com
Metabolomic Platform Market Size, Growth | Soaring Demand | 2023 - 2029
March 15, 2023 | marketwatch.com
Prostate Cancer Screening Market 2023-2030 With Highly Productive Segment To Expand Outstandingly
March 13, 2023 | finance.yahoo.com
MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
March 9, 2023 | finanznachrichten.de
mdxhealth: MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
March 8, 2023 | finance.yahoo.com
MDxHealth Announces Update of Outstanding Shares and Voting Rights
March 6, 2023 | finance.yahoo.com
MDxHealth Announces Exercise of Option
March 3, 2023 | marketwatch.com
Oncology Precision Medicine Market Environment Development Trend in 2023
March 1, 2023 | msn.com
$4M Bet On MDxHealth? Check Out These 4 Penny Stocks Insiders Are Buying
March 1, 2023 | finance.yahoo.com
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
February 22, 2023 | finance.yahoo.com
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
February 15, 2023 | finance.yahoo.com
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
February 15, 2023 | finance.yahoo.com
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
February 13, 2023 | finance.yahoo.com
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
See More Headlines
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Company Calendar

Today
4/02/2023
Next Earnings (Estimated)
4/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDXH
CUSIP
N/A
CIK
1872529
Web
mdxhealth.com
Phone
324-364-2070
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+270.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-44,040,000.00
Net Margins
-118.86%
Pretax Margin
-118.86%
Return on Equity
-218.20%
Return on Assets
-44.01%

Debt

Debt-to-Equity Ratio
4.08
Current Ratio
1.59
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$37.05 million
Price / Sales
1.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
5.68

Miscellaneous

Outstanding Shares
16,290,000
Free Float
16,011,000
Market Cap
$52.78 million
Optionable
Not Optionable
Beta
0.29

Key Executives

  • Mr. Michael K. McGarrity (Age 59)
    CEO & Exec. Director
    Comp: $502.44k
  • Mr. Ron Kalfus (Age 48)
    Chief Financial Officer
  • Mr. Joseph Sollee (Age 57)
    Exec. VP of Corp. Devel. & Gen. Counsel
  • Mr. John A. Bellano (Age 53)
    Chief Commercial Officer
  • Ms. Miriam Reyes (Age 49)
    Exec. VP of Operations
  • Dr. Wim Van Criekinge (Age 50)
    Chief Scientific Officer
  • Mr. Paul Marr
    Exec. VP of Sales for North America

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MDXH Stock - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings or view top-rated stocks.

What is MDxHealth's stock price forecast for 2023?

4 Wall Street analysts have issued 1-year target prices for MDxHealth's stock. Their MDXH share price forecasts range from $8.00 to $18.00. On average, they predict the company's stock price to reach $12.00 in the next year. This suggests a possible upside of 270.4% from the stock's current price.
View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts.

How have MDXH shares performed in 2023?

MDxHealth's stock was trading at $6.61 on January 1st, 2023. Since then, MDXH stock has decreased by 51.0% and is now trading at $3.24.
View the best growth stocks for 2023 here.

When is MDxHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our MDXH earnings forecast.

When did MDxHealth IPO?

(MDXH) raised $45 million in an IPO on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.

What is MDxHealth's stock symbol?

MDxHealth trades on the NASDAQ under the ticker symbol "MDXH."

How do I buy shares of MDxHealth?

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MDxHealth's stock price today?

One share of MDXH stock can currently be purchased for approximately $3.24.

How much money does MDxHealth make?

MDxHealth (NASDAQ:MDXH) has a market capitalization of $52.78 million and generates $37.05 million in revenue each year. The company earns $-44,040,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center, Herstal, Liege 4040. The official website for the company is mdxhealth.com. The company can be reached via phone at 324-364-2070 or via email at ir@mdxhealth.com.

This page (NASDAQ:MDXH) was last updated on 4/2/2023 by MarketBeat.com Staff